• Tidak ada hasil yang ditemukan

Schedule for the Month of November 2021

N/A
N/A
Protected

Academic year: 2023

Membagikan "Schedule for the Month of November 2021"

Copied!
7
0
0

Teks penuh

(1)

DEPARTMENT OF PATHOLOGY

CBME SCHEDULE FOR THE MONTH OF NOVEMBER 2021

Days Lecture 8-9 AM

Staff 11-1 PM Staff 2-4 PM 4-5 PM

SDL

Staff Monday

01.11.2021

HOLIDAY Tuesday

02.11.2021

PA 25 FA Dr. Aravind P

Pathology DOAP A PA 25.6

Dr. Aravind P Dr. Manjushree Dr. Shirley Wednesday

03.11.2021

HOLIDAY Thursday

04.11.2021

PA 28.12 PA 28.13 PA 29.1 PA 29.2

Dr. Sandhya I Pathology SGD A REVISION PA 28

Dr. Sandhya I Dr. Manjushree Dr. Shirley Friday

05.11.2021 HOLIDAY

Saturday 06.11.2021

LECTURE:

PA 25 (Formative Assessment) Hepatobiliary

PA28.12 Define classify and describe the genetics, inheritance, etiology, pathogenesis, pathology, laboratory, urinary findings, distinguishing features, progression and complications of cystic disease of the kidney

PA28.13 Define classify and describe the etiology, pathogenesis, pathology, laboratory, urinary findings, distinguishing features progression and complications of renal stone disease and obstructive uropathy PA29.1 Classify testicular tumours and describe the pathogenesis, pathology, presenting and

distinguishing features, diagnostic tests, progression and spread of testicular tumours

PA29.2 Describe the pathogenesis, pathology, presenting and distinguishing features, diagnostic tests, progression and spread of carcinoma of the penis

SGD

REVISION PA 28 DOAP:

CCT: CERTIFIABLE COMPETENCY TEST PA 25.6: Interpret liver function and viral hepatitis serology panel. Distinguish obstructive from non-obstructive jaundice based on clinical features and liver function tests

(2)

8-9 AM SDL Monday

08.11.2021

FA PA 28 Dr. Reba Philipose

PA 32.6 Dr. Reba Philipose Tuesday

09.11.2021

PA 30.1 PA 30.6

Dr. Purnima S Rao

Pathology DOAP A PA 28

Dr. Reba Philipose Dr. Samridhi Dr. Sameeksha Wednesday

10.11.2021

PA 29.3 PA 29.4 PA 29.5

Dr. Reba Philipose

Pathology SGD: DOAP B PA 29

Dr. Purnima S Rao Dr. Samridhi Dr. Sameeksha.

Thursday 11.11.2021

PA 30.7 PA 30.8 PA 30.9

Dr. Purnima S Rao

Pathology SGD: DOAP A PA29

Dr. Purnima S Rao Dr. Samridhi Dr. Sameeksha Friday

12.11.2021

PA 30.4 PA 30.2

Pathology DOAP B PA 28

Dr. Reba Philipose Dr. Samridhi Dr. Sameeksha Saturday

13.11.2021

LECTURE:

PA29.3 Describe the pathogenesis, pathology, hormonal dependency presenting and distinguishing features, urologic findings & diagnostic tests of benign prostatic hyperplasia

PA29.4 Describe the pathogenesis, pathology, hormonal dependency presenting and distinguishing features, diagnostic tests, progression and spread of carcinoma of the prostate

PA29.5 Describe the etiology, pathogenesis, pathology and progression of prostatitis

PA-30.1 - Describe the epidemiology, pathogenesis, etiology, pathology, screening, diagnosis and progression of carcinoma of the Cervix.

PA-30.6 - Describe the etiology and morphologic features of cervicitis

PA-30.7 - Describe the etiology, hormonal dependence, features and morphology of endometriosis.

PA-30.8 - Describe the etiology and morphologic features of adenomyosis.

PA-30.9 - Describe the etiology, hormonal dependence and morphology of endometrial hyperplasia SGD:

PA-28 - Urinary system Specimen- Chronic pyelonephritis, Renal stones with hydronephrosis, Renal cell carcinoma

Slide- Chronic pyelonephritis, Renal cell carcinoma SGD : DOAP PA-29 - Male genital system

Specimen- Seminoma testis, Carcinoma penis Slide-Seminoma testis, Benign prostatic hyperplasia SDL:

PA 32.6 - Describe, etiology, pathogenesis, manifestations, laboratory, morphologic features, complications and metastases of pancreatic cancer

(3)

8-9 AM SDL Monday

15.11.2021

FA PA 29 Dr. Sandhya I PA 32.7 Dr. Prithal G

Tuesday 16.11.2021

PA 30.2 Dr. Aravind P Pathology

DOAP A PA 31

Dr. Sandhya I Dr. Priyadarshini Dr. Prabhina Wednesday

17.11.2021

PA 30.4 PA 30.5

Dr. Sandhya I Pathology DOAP B PA 30

Dr. Aravind P Dr. Priyadarshini Dr. Prabhina Thursday

18.11.2021

PA 31.1 PA 31.2 PA 31.4

Dr. Aravind P Pathology DOAP A PA 30

Dr. Aravind P Dr. Priyadarshini Dr. Prabhina Friday

19.11.2021

Pathology DOAP B PA 31

Dr. Sandhya I Dr. Priyadarshini Dr. Prabhina Saturday

20.11.2021

LECTURE:

PA-30.2 - Describe the pathogenesis, etiology, pathology, diagnosis and progression and spread of carcinoma of the endometrium

PA 30.4 - Classify and describe the etiology, pathogenesis, pathology, morphology, clinical course, spread and complications of ovarian tumours

PA 30.5 - Classify and describe the etiology, pathogenesis, pathology, morphology, clinical course, spread and complications of Gestational trophoblastic diseases.

PA-31.1 - Classify and describe the types, etiology, pathogenesis, hormonal dependency of breast pathology and benign disease

PA 31.2 – Classify and describe the epidemiology, pathogenesis, classification, morphology, prognostic factors, hormonal dependency, staging and spread of Carcinoma breast

PA-31.4 - Enumerate and describe the etiology, hormonal dependency and pathogenesis of gynecomastia.

SGD: DOAP

PA 30 Female genital system

Specimen-Leiomyoma, Carcinoma cervix, Benign Cystic Teratoma, Serous/Mucinous Cystadenoma. Hydatidiform mole (Optional).

Slides- Leiomyoma, Serous/Mucinous Cystadenoma, Hydatidiform mole.

Benign Cystic Teratoma (Optional) DOAP:

PA-31 - Breast

Specimen- Fibroadenoma. Carcinoma breast (Optional) Slide- Fibroadenoma. Carcinoma breast (Optional) SDL: 32.7 Adrenal Insufficiency

(4)

8-9 AM SDL Monday

22.11.2021

FA PA 30 Dr. Lovely George

PA 32.8 Dr Lovely George Tuesday

23.11.2021

PA 33.1 PA 33.2

Dr. Prithal G Pathology

DOAP A PA 32

Dr. Lovely George Dr.Prasanjith Dr.Fareeda Wednesday

24.11.2021

PA 32.1 Dr. Lovely George

Pathology SGD B PA 32.2 PA 32.3

Dr. Prithal G Dr. Prasanjith Dr. Fareeda.

Thursday 25.11.2021

PA 32.4 Dr. Prithal G Pathology SGD A PA 32.2 PA 32.3

Dr. Prithal G Dr. Prasanjith Dr. Fareeda Friday

26.11.2021

Pathology DOAP B PA 32

Dr. Lovely George Dr. Prasanjith Dr. Fareeda.

Saturday 27.11.2021

LECTURE:

PA32.1 Enumerate, classify and describe the etiology, pathogenesis, pathology and iodine dependency of thyroid swellings with Thyroid neoplasms

PA32.4 Classify and describe the epidemiology, etiology, pathogenesis, pathology, clinical laboratory features, complications and progression of diabetes mellitus

PA33.1 Classify and describe the etiology, pathogenesis, manifestations, radiologic and morphologic features and complications of osteomyelitis

PA33.2 Classify and describe the etiology, pathogenesis, manifestations, radiologic and morphologic features and complications and metastases of bone tumours

SGD:

PA-32.2 - Describe the etiology, cause, iodine dependency, pathogenesis, manifestations, laboratory and imaging features and course of thyrotoxicosis.

PA-32.3 - Describe the etiology, pathogenesis, manifestations, laboratory and imaging features and course of thyrotoxicosis/ hypothyroidism TFT CHARTS

DOAP:

PA 32 Multinodular goitre, Hashimoto’s SDL: Cushing’s syndrome.

(5)

8-9 AM PM SDL Monday

29.11.2021

FA PA 31 PA 32

Dr. Purnima S Rao PA 32.9 Dr. Purnima S Rao

Tuesday 30.11.2021

PA 34.1 PA 34.2 PA 34.3

Dr. Reba Philipose Pathology

DOAP A PA 33

Dr. Reba Philipose Dr. Manjushree Dr. Shirley

LECTURE:

PA34.1 Describe the risk factors pathogenesis, pathology and natural history of squamous cell carcinoma of the skin

PA34.2 Describe the risk factors pathogenesis, pathology and natural history of basal cell carcinoma of the skin

PA34.3 Describe the distinguishing features between a nevus and melanoma. Describe the etiology, pathogenesis, risk factors morphology clinical features and metastases of melanoma

DOAP:

PA 33 Bone tumors

Specimen- Osteoclastoma, Osteosarcoma Slide- Osteoclastoma. Osteosarcoma (Optional)

SDL: PA-32.9 - Describe the etiology, pathogenesis, manifestations, laboratory and morphologic features of adrenal neoplasms

Prepared By: Dr. Sandhya I Dr. Thoppil Reba Philipose

Professor& HOD of pathology

(6)

A.J.INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE DEPARTMENT OF PATHOLOGY

MBBS ODD BATCH SCHEDULE FOR THE MONTH OF NOVEMBER 2021

Date Topic Staff

2-11-2021 Classification of hepatic tumors - Hepatocellular

carcinoma - Etiopathogenesis, Morphology, Clinical

features and Diagnosis. Briefly about fibrolamellar

carcinoma.

Dr. Shreya Hegde

3-11-2021 HOLIDAY

4-11-2021 Cholelithiasis – Definition, Types, Etiopathogenesis,

Morphology of acute and chronic cholecystitis,

Clinical features and Complications

Dr. Shreya Hegde

9-11-2021 Acute and chronic pancreatitis- Etiology, Pathogenesis, Morphology, Clinical features, Long

term outcome

Dr. Vinitha Samartha

10-11-2021 REVISION Dr. Vinitha Samartha

Dr. Mounica 11-11-2021 Pancreatic carcinoma – Pathogenesis, Clinical

features and Morphology

Dr. Vinitha Samartha

16.11.2021 Introduction-The normal structure and function of

kidney, Clinical manifestation of renal diseases, RFT.

Dr .Shreya

Hegde

17.11.2021 SLIDES:

TUBERCULOSIS INTESTINE CARCINOMA ESOPHAGUS GROSS:

PEPTIC ULCER

CARCINOMA OESOPHAGUS TB INTESTINE

INTESTINAL POLYP

Dr .Shreya

Hegde

Dr. Mounica

18.11.2021 Nephrotic syndrome - Definition, and

Etiopathogenesis, Morphology, Clinical features, Lab diagnosis and Clinical course of Minimal change disease, Focal Segmental

Glomerulosclerosis.

Dr. Shreya

Hegde

23.11.2021 Pathogenesis of glomerular injury. Classification of glomerular diseases. Histologic alterations in

Dr. Vinitha

Samartha

(7)

24.11.2021 PERIPHERAL SMEAR: EOSINOPHILIA Dr. Vinitha

Samartha

Dr. Mounica

25.11.2021 Nephritic Syndrome –Definition, and

Etiopathogenesis, Morphology, Clinical features &

Lab diagnosis and Clinical course Post streptococcal GN and RPGN.

Dr. Vinitha

Samartha

30.11.2021 Etiopathogenesis, Morphology, Clinical features, Lab diagnosis and Clinical course of

Membranoproliferative glomerulonephritis, and Membranous Nephropathy.

Dr. Shreya

Hegde

Prepared By: Dr. Sandhya I Dr. Reba Philipose

Professor& HOD Pathology

Referensi

Dokumen terkait

This research is concerned with Indonesian students‟ willingness to communicate in English class at Islamic high school context. This study aims to identify factor